In RA, hypoxia and lipid peroxidation shape a synovium where PD-L1 arrives late and soft; abatacept remains foundational, and metabolic tempering can make later PD-1 signalling meaningful. The gene discussed is PDCD1; the disease is rheumatoid arthritis.